187Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of
chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res
Cardiol 101:43–52
Cerra MC, Gallo MP, Angelone T, Quintieri AM, Pulerà E, Filice E et al (2008) The homologous
rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart
to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB
J 22:3992–4004
Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C (2009) MicroRNA-21 protects against the H2O2-
induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47:5–14
Cohen MV, Downey JM (2008) Adenosine: trigger and mediator of cardioprotection. Basic Res
Cardiol 103:203–215
Cohen MV, Downey JM (2011) Ischemic postconditioning: from receptor to end-effector. Antioxid
Redox Signal 14:821–831
Cohen MV, Baines CP, Downey JM (2000) Ischemic preconditioning: from adenosine receptor to
KAT P channel. Annu Rev Physiol 62:79–109
Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM (2001) Acetylcholine, bradykinin, opioids,
and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and
opening mitochondrial KATP channels. Circ Res 89:273–278
Cohen MV, Yang XM, Downey JM (2006) Nitric oxide is a preconditioning mimetic and cardiopro-
tectant and is the basis of many available infarct sparing strategies. Cardiovasc Res 70:231–239
Craig R, Wagner M, McCardle T, Craig AG, Glembotski CC (2001) The cytoprotective effects
of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of
NF-kappa B. J Biol Chem 276:37621–37629
Dan Dunn J, Alvarez LA, Zhang X, Soldati T (2015) Reactive oxygen species and mitochondria: a
nexus of cellular homeostasis. Redox Biol 6:472–485
Dawn B, Bolli R (2002) Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci
962:18–41
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X et al (2009) MicroRNA expression signature
and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem
284:29514–29525
Ferdinandy P, Schulz R (2003) Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-
reperfusion injury and preconditioning. Br J Pharmacol 138:532–543
Filice E, Pasqua T, Quintieri AM, Cantafio P, Scavello F, Amodio N et al (2015) Chromofungin,
CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotec-
tive action during ischemia/reperfusion injury. Peptides 71:40–48
Forbes RA, Steenbergen C, Murphy E (2001) Diazoxide induced cardioprotection requires signal-
ing through a redox-sensitive mechanism. Circ Res 88:802–809
Frydland M, Kousholt B, Larsen JR, Burnettr JC Jr, Hilsted L, Hasenkam JM et al (2013)
Increased N-terminal CgA in circulation associated with cardiac reperfusion in pigs. Biomark
Med 7:959–967
Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV et al (2008) Signal
transducer and activator of transcription 3 is involved in the cardioprotective signalling path-
way activated by insulin therapy at reperfusion. Basic Res Cardiol 103:444–453
Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K (2000) Akt promotes survival of cardiomy-
ocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation
101:660–667
Gallo MP, Levi R, Ramella R, Brero A, Boero O, Tota B et al (2007) Endothelium-derived nitric
oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium.
Am J Physiol Heart Circ Physiol 292:H2906–H2912
Garcia-Dorado D, Agulló L, Sartorio CL, Ruiz-Meana M (2009) Myocardial protection against
reperfusion injury: the cGMP pathway. Thromb Haemost 101:635–642
Cardioprotection and Chromogranin A-Derived Peptides